Quick Takeaways
- 7. Cooperative Ua Lsp filed SCHEDULE 13D for Evommune, Inc. Common Stock, $0.0001 par value per share.
- Disclosed ownership: 16%.
- Date of event: 07 Nov 2025.
7. Cooperative Ua Lsp - 07 Nov 2025 SCHEDULE 13D Report for Evommune, Inc. Common Stock, $0.0001 par value per share
- Filing Manager
- 7. Cooperative Ua Lsp
- Reporting Manager
- LSP 7 Cooperatieve U.A.
- Shares outstanding
- 31,398,936 shares
- Disclosed Ownership
- 4,929,633 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D
- Filing time
- 14 Nov 2025, 16:30:44 UTC
- Date of event
- 07 Nov 2025
- Next filing
- 19 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"7. Cooperative Ua Lsp disclosed 16% ownership in Evommune, Inc. Common Stock, $0.0001 par value per share on 07 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LSP 7 Cooperatieve U.A. | 16% | 4,929,633 | 0 | 4,929,633 | By: LSP 7 Management B.V., its sole director, By: /s/ Martijn Kleijwegt | Martijn Kleijwegt, Managing Director | 0001876264 |
| LSP 7 Management B.V. | 16% | 4,929,633 | 0 | 4,929,633 | /s/ Martijn Kleijwegt | Martijn Kleijwegt, Managing Director |